Skip to main content
Data & APIs
Events
Marketfy
Premarket Prep
Contribute
Login
Join
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Retail Sales
Offerings
IPOs
Insider Trades
Biotech/FDA
Freight
Tech
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Reviews
Small-Cap
Cryptocurrency
Penny Stocks
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Penny Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best S&P 500 ETFs
Best Small Cap ETFs
Best Swing Trade Stocks
Fintech
Personal Finance
Stock Brokers
Forex Brokers
Personal Finance
Futures Brokers
Cryptocurrency Brokers
Webull
Binary Option Brokers
Options Brokers
eToro
Altcoin Exchanges
Ally Invest Review
Binary Options Review
eOption Review
Etrade Review
Interactive Brokers Review
Personal Capital Review
Suretrader Review
TD Ameritrade Review
Tradestation Review
Yewno|Edge Review
Cobra Trading Review
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Invest in Art
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Masterworks Review
Motorcycle
Renters
Workers Comp
Refinance
Purchase
Find a Mortgage Broker
Crypto
Crypto News
Bitcoin
Ethereum
Blockchain
Best Alt Coins
How to buy Crypto
TV
YouTube
Video
Podcasts
Tools
Earnings Calendar
IPO Calendar
Guidance Calendar
FDA Calendar
Dividend Calendar
Stock Split Calendar
Conference Call Calendar
Economic Calendar
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Premium
Market Overview
Tickers, Articles and Keywords:
Tickers
Articles
Keywords
Search by keyword...
googlecse
WANT TO CATCH
ACT
NEWS
BEFORE
IT CHANGES THE STOCK PRICE?
More From
Summary
Ideas
Twitter ($)
All News
Analyst Coverage
Analyst Ratings
News Coverage
News
General
Contracts
Dividend Summaries
Dividend Calendar
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Press Releases
Earnings
Earning Summaries
Earnings Calendar
Guidance Summaries
Enact Holdings, Inc.
ACT
:NASDAQ
Add to Watchlist +
Trade
{{ portfolio.portfolio_name }}
You have no watchlists at this time, click "Manage watchlists" to create your first watchlist.
Manage watchlists
Sector:
Financials
Industry:
Financial Services
36.28
-0.71 (-1.92%)
After Hours 36.28
(%)
Data as of Sep 21, 2024
Prev. Close
36.99
Price Open
36.86
Volume
563,422
Day's Range
36.19 - 36.885
52 Wk Range
26.13 - 37.085
50 Day Moving Avg.
34.31
PE Ratio
8.891827
Shares Outstanding
155.70M
Market Cap
5.65B
Trade ACT stock for free with
recommended broker TD Ameritrade
.
1d
5d
1m
3m
1y
5y
YTD
Analyst Rating
View All Ratings
Date
Research Firm
Action
Current
Target
10/12/21
Citigroup
Initiates Coverage On
Buy
24.0
10/11/21
JP Morgan
Initiates Coverage On
Overweight
25.0
10/11/21
Credit Suisse
Initiates Coverage On
Neutral
24.0
Headlines
Press Releases
Actavis plc Becomes Allergan plc
Charles Gross
Mon, 15 Jun 2015 07:04:43 -0400
Amneal to Acquire Generic Business of Actavis Australia
Charles Gross
Mon, 30 Mar 2015 20:38:53 -0400
Actavis Announces Closing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan
Eddie Staley
Thu, 12 Mar 2015 16:31:56 -0400
Actavis Announces Proposed Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan
Eddie Staley
Thu, 19 Feb 2015 08:40:06 -0400
Actavis to Adopt 'Allergan' Corporate Name
Charles Gross
Wed, 18 Feb 2015 08:03:08 -0400
AstraZeneca to Acquire Rights to Actavis' Branded Respiratory Business in U.S., Canada for Initial Consideration of $600M
Charles Gross
Thu, 05 Feb 2015 05:38:28 -0400
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC
Eddie Staley
Mon, 26 Jan 2015 18:36:14 -0400
Richter, Actavis Announce Positive Phase III Results for Cariprazine in Prevention of Relapse in Patients with Schizophrenia
Charles Gross
Tue, 20 Jan 2015 05:31:38 -0400
Adamas Pharmaceuticals Recaps 2014 Acheivements, Previews Upcoming Business Drivers
Charles Gross
Sun, 11 Jan 2015 20:30:39 -0400
Actavis, Gedeon Richter Announce FDA Receives NDA Resubmission for Cariprazine
Charles Gross
Tue, 06 Jan 2015 06:00:05 -0400
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
Actavis plc (ACT) gains on Q1 results
Accesswire
May 11, 2015
Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
Newswire
Feb 01, 2013
Actavis Confirms District Court Ruling In Generic Rapamune® Patent Suit
Newswire
Jan 31, 2013
FDA Approves OXYTROL® FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women
Newswire
Jan 25, 2013
Actavis Details Strategy for Continued Long-Term Growth
Newswire
Jan 25, 2013
Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
Newswire
Jan 24, 2013
Fashion Cares 25 Announces 2012 Honourary Chairs
Benzinga Staff
Apr 19, 2012
Magellan Health Services of Arizona Receives National Recognition for Suicide Prevention Program
Benzinga Staff
Apr 16, 2012
Indigenous Tribe Earns Validation for Landmark Forest Carbon Project
Benzinga Staff
Apr 12, 2012
Datacard Group Strengthens Instant Issuance & EMV® Smart Card Technology Expertise in Canada
Benzinga Staff
Apr 10, 2012
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
Partner Headlines
Cannabis Initiative With Amy Margolis (Podcast Transcript)
Seeking Alpha
Dec 13, 2019
Cannabis Initiative With Amy Margolis (Podcast)
Seeking Alpha
Dec 11, 2019
Transparency Is Fundamental In The CBD Space With Marshall Getto (Podcast Transcript)
Seeking Alpha
Dec 05, 2019
November Marijuana Market Performance Sliced & Diced By Segment
TalkMarkets
Dec 05, 2019
Transparency Is Fundamental In The CBD Space With Marshall Getto
Seeking Alpha
Dec 04, 2019
November Performance Of The Market's 15 Cannabis ETFs Ranged From +6.1% To -14.4%
TalkMarkets
Dec 02, 2019
Normalizing Cannabis Retail With Nicole Fox (Podcast Transcript)
Seeking Alpha
Nov 29, 2019
Normalizing Cannabis Retail With Nicole Fox
Seeking Alpha
Nov 27, 2019
Hemp, CBD And Cannabis With Josh Drayton And Alex Seleznov
Seeking Alpha
Nov 20, 2019
Scotts Miracle-Gro Is A Bullish Beast
Seeking Alpha
Nov 19, 2019
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
Earnings
View Earnings
Q4 2021
EST
Actual
Surprise
EPS:
0.830
0.940
0.1100
Rev:
279.92M
272.84M
-7.08M
Q1 2022
EST
Actual
Surprise
EPS:
Expected
2022-05-25
Rev: